SYNALAR-HP Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Synalar-hp, and what generic alternatives are available?
Synalar-hp is a drug marketed by Medimetriks Pharms and is included in one NDA.
The generic ingredient in SYNALAR-HP is fluocinolone acetonide. There are twelve drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the fluocinolone acetonide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Synalar-hp
A generic version of SYNALAR-HP was approved as fluocinolone acetonide by TARO on April 27th, 1982.
Summary for SYNALAR-HP
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 79 |
Clinical Trials: | 2 |
Patent Applications: | 4,309 |
Formulation / Manufacturing: | see details |
DailyMed Link: | SYNALAR-HP at DailyMed |
Recent Clinical Trials for SYNALAR-HP
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Noah Rosenberg, MD | Phase 4 |
LEO Pharma | Phase 1 |
Anatomical Therapeutic Chemical (ATC) Classes for SYNALAR-HP
US Patents and Regulatory Information for SYNALAR-HP
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Medimetriks Pharms | SYNALAR-HP | fluocinolone acetonide | CREAM;TOPICAL | 016161-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |